Cilazapril: Difference between revisions
Jump to navigation
Jump to search
m Protected "Cilazapril": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
Line 1: | Line 1: | ||
{{drugbox | | {{drugbox | | ||
| IUPAC_name = (5''S'',8''S'')-5-{[(1''S'')-1-ethoxycarbonyl-3-phenyl-propyl]<br>amino}-6-oxo-1,7-diazabicyclo[5.4.0]undecane-8-<br>carboxylic acid | | IUPAC_name = (5''S'',8''S'')-5-{[(1''S'')-1-ethoxycarbonyl-3-phenyl-propyl]<br>amino}-6-oxo-1,7-diazabicyclo[5.4.0]undecane-8-<br>carboxylic acid | ||
| image = Cilazapril. | | image = Cilazapril.PNG | ||
| CAS_number = 92077-78-6 | | CAS_number = 92077-78-6 | ||
| ATC_prefix = C09 | | ATC_prefix = C09 | ||
Line 23: | Line 23: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
{{ACE | {{CMG}} {{SS}} | ||
{{ | |||
'''Cilazapril''' is an [[angiotensin-converting enzyme]] inhibitor ([[ACE inhibitor]]) used for the treatment of [[hypertension]] and [[congestive heart failure]].<ref>{{cite pmid|1712267}}</ref><ref>{{cite book|title=Austria-Codex|editor=Jasek, W|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=2007/2008|isbn=978-3-85200-181-4|language=German}}</ref> It is branded as '''Inhibace''' in Canada and other countries, '''Vascace''' and '''Dynorm''' in a number of European countries, among many other names. None of these are available in the [[United States]] as of May 2010.<ref>Drugs.com: [http://www.drugs.com/international/cilazapril.html Cilazapril]</ref> | |||
Of the eight possible [[stereoisomers]], only the all-''S'' form is medically viable.{{citation needed|date=February 2012}} | |||
{{Reflist|2}} | |||
[[Category:ACE inhibitors]] | [[Category:ACE inhibitors]] | ||
[[Category:Cardiovascular Drugs]][[Category:Drugs]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} |
Revision as of 19:27, 23 July 2014
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H33N3O6 |
Molar mass | 435.514 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Sheng Shi, M.D. [2]
Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure.[1][2] It is branded as Inhibace in Canada and other countries, Vascace and Dynorm in a number of European countries, among many other names. None of these are available in the United States as of May 2010.[3]
Of the eight possible stereoisomers, only the all-S form is medically viable.[citation needed]
- ↑ PMID 1712267 (PMID 1712267)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ Jasek, W, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
- ↑ Drugs.com: Cilazapril
Categories:
- Pages with script errors
- Pages with incomplete PMID references
- CS1 maint: Unrecognized language
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from February 2012
- Articles with invalid date parameter in template
- ACE inhibitors
- Cardiovascular Drugs
- Drugs